Abstract
Tox21 is a collaborative effort among the National Center for Advancing Translational Sciences, the Environmental Protection Agency, the National Toxicology Program, and the Food and Drug Administration to elucidate the toxic effects of compounds found in the environment and/or created by humans. Since 2008, this program has screened many different pathways, targets, or phenotypes (more than 70 assays) using an in vitro quantitative high-throughput screening approach. Endocrine disruption and stress-related signaling pathways have been the main focus of the Tox21 screening program. Nuclear receptors play an important role in endocrine disruption, modulating many different biological processes and metabolism. It is therefore important to classify endogenous and exogenous compounds for their ability to alter the function or quantity of these nuclear receptors. Stress-related signaling pathways are necessary for body homeostasis and are involved in many disease states as well. Identifying compounds which induce stress signaling pathways in the body is prudent to fully determine the safety of an environmental chemical. This book chapter describes an in-depth analysis of Tox21, a summary of select examples of their assays, and the future plan for the screening program.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ademuyiwa O, Ugbaja RN, Rotimi SO, Abam E, Okediran BS, Dosumu OA, Onunkwor BO (2007) Erythrocyte acetylcholinesterase activity as a surrogate indicator of lead-induced neurotoxicity in occupational lead exposure in Abeokuta, Nigeria. Environ Toxicol Pharmacol 24(2):183–188. https://doi.org/10.1016/j.etap.2007.05.002
Attene-Ramos MS, Huang R, Michael S, Witt KL, Richard A, Tice RR, Simeonov A, Austin CP, Xia M (2015) Profiling of the Tox21 chemical collection for mitochondrial function to identify compounds that acutely decrease mitochondrial membrane potential. Environ Health Perspect 123(1):49–56. https://doi.org/10.1289/ehp.1408642
Attene-Ramos MS, Huang RL, Sakamuru S, Witt KL, Beeson GC, Shou L, Schnellmann RG, Beeson CC, Tice RR, Austin CP, Xia MH (2013) Systematic study of mitochondria! toxicity of environmental chemicals using quantitative high throughput screening. Chem Res Toxicol 26(9):1323–1332. https://doi.org/10.1021/tx4001754
Bi K, Nishihara K, Machleidt T, Hermanson S, Wang J, Sakamuru S, Huang R, Xia M (2015) Identification of known drugs targeting the endoplasmic reticulum stress response. Anal Bioanal Chem 407(18):5343–5351. https://doi.org/10.1007/s00216-015-8694-2
Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C (2012) The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model. Health Technol Assess 16 (21):1–470. https://doi.org/10.3310/hta16210
Chang C, Lee SO, Yeh S, Chang TM (2014) Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene 33(25):3225–3234. https://doi.org/10.1038/onc.2013.274
Chen LB (1988) Mitochondrial membrane potential in living cells. Annu Rev Cell Biol 4:155–181. https://doi.org/10.1146/annurev.cb.04.110188.001103
Chen S, Hsieh JH, Huang R, Sakamuru S, Hsin LY, Xia M, Shockley KR, Auerbach S, Kanaya N, Lu H, Svoboda D, Witt KL, Merrick BA, Teng CT, Tice RR (2015) Cell-based high-throughput screening for aromatase inhibitors in the Tox21 10 K library. Toxicol Sci 147(2):446–457. https://doi.org/10.1093/toxsci/kfv141
Chen Y, Sakamuru S, Huang R, Reese DH, Xia M (2016) Identification of compounds that modulate retinol signaling using a cell-based qHTS assay. Toxicol Vitr 32:287–296. https://doi.org/10.1016/j.tiv.2016.01.011
Colovic MB, Krstic DZ, Lazarevic-Pasti TD, Bondzic AM, Vasic VM (2013) Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol 11(3):315–335. https://doi.org/10.2174/1570159X11311030006
Culig Z, Klocker H, Bartsch G, Hobisch A (2002) Androgen receptors in prostate cancer. Endocr Relat Cancer 9(3):155–170
Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
Farkas DL, Wei MD, Febbroriello P, Carson JH, Loew LM (1989) Simultaneous imaging of cell and mitochondrial membrane potentials. Biophys J 56(6):1053–1069. https://doi.org/10.1016/S0006-3495(89)82754-7
FDA’s Predictive Toxicology Roadmap (2017)
Fernandez HL, Moreno RD, Inestrosa NC (1996) Tetrameric (G4) acetylcholinesterase: structure, localization, and physiological regulation. J Neurochem 66(4):1335–1346
Fox JT, Sakamuru S, Huang R, Teneva N, Simmons SO, Xia M, Tice RR, Austin CP, Myung K (2012) High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. Proc Natl Acad Sci USA 109(14):5423–5428. https://doi.org/10.1073/pnas.1114278109
Fradet A, Bouchet M, Delliaux C, Gervais M, Kan C, Benetollo C, Pantano F, Vargas G, Bouazza L, Croset M, Bala Y, Leroy X, Rosol TJ, Rieusset J, Bellahcene A, Castronovo V, Aubin JE, Clezardin P, Duterque-Coquillaud M, Bonnelye E (2016) Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone. Oncotarget 7(47):77071–77086. https://doi.org/10.18632/oncotarget.12787
Freitas J, Miller N, Mengeling BJ, Xia M, Huang R, Houck K, Rietjens IM, Furlow JD, Murk AJ (2014) Identification of thyroid hormone receptor active compounds using a quantitative high-throughput screening platform. Curr Chem Genom Transl Med 8:36–46. https://doi.org/10.2174/2213988501408010036
Gao J, Xie W (2010) Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism. Drug Metab Dispos 38(12):2091–2095. https://doi.org/10.1124/dmd.110.035568
Giacobini E (2000) Cholinesterase inhibitors stabilize Alzheimer’s disease. Ann N Y Acad Sci 920:321–327
Gibb S (2008) Toxicity testing in the 21st century: a vision and a strategy. Reprod Toxicol 25(1):136–138. https://doi.org/10.1016/j.reprotox.2007.10.013
Giguere V (1999) Orphan nuclear receptors: from gene to function. Endocr Rev 20(5):689–725. https://doi.org/10.1210/edrv.20.5.0378
Gonzalez TL, Rae JM, Colacino JA (2019) Implications of Environmental estrogen and anti-androgen exposure on human health: a focus on the relationship between estrogenicity and breast cancer. Toxicology. https://doi.org/10.1016/j.tox.2019.03.014
Greaves P, Williams A, Eve M (2004) First dose of potential new medicines to humans: how animals help. Nat Rev Drug Discov 3(3):226–236. https://doi.org/10.1038/nrd1329
Guo J, Tang Q, Wang Q, Sun W, Pu Z, Wang J, Bao Y (2019) Pifithrin-alpha enhancing anticancer effect of topotecan on p53-expressing cancer cells. Eur J Pharm Sci 128:61–72. https://doi.org/10.1016/j.ejps.2018.11.024
Hancock MK, Xia M, Frey ES, Sakamuru S, Bi K (2009) HTS-compatible beta-lactamase transcriptional reporter gene assay for interrogating the heat shock response pathway. Curr Chem Genomics 3:1–6. https://doi.org/10.2174/1875397300903010001
He G, Tsutsumi T, Zhao B, Baston DS, Zhao J, Heath-Pagliuso S, Denison MS (2011) Third-generation Ah receptor-responsive luciferase reporter plasmids: amplification of dioxin-responsive elements dramatically increases CALUX bioassay sensitivity and responsiveness. Toxicol Sci 123(2):511–522. https://doi.org/10.1093/toxsci/kfr189
Hedrich WD, Xiao J, Heyward S, Zhang Y, Zhang J, Baer MR, Hassan HE, Wang H (2016) Activation of the constitutive androstane receptor increases the therapeutic index of CHOP in lymphoma treatment. Mol Cancer Ther 15(3):392–401. https://doi.org/10.1158/1535-7163.MCT-15-0667
Holas O, Musilek K, Pohanka M, Kuca K (2012) The progress in the cholinesterase quantification methods. Expert Opin Drug Discov 7(12):1207–1223. https://doi.org/10.1517/17460441.2012.729037
Hsu CW, Hsieh JH, Huang R, Pijnenburg D, Khuc T, Hamm J, Zhao J, Lynch C, van Beuningen R, Chang X, Houtman R, Xia M (2016a) Differential modulation of FXR activity by chlorophacinone and ivermectin analogs. Toxicol Appl Pharmacol 313:138–148. https://doi.org/10.1016/j.taap.2016.10.017
Hsu CW, Huang R, Khuc T, Shou D, Bullock J, Grooby S, Griffin S, Zou C, Little A, Astley H, Xia M (2016b) Identification of approved and investigational drugs that inhibit hypoxia-inducible factor-1 signaling. Oncotarget 7(7):8172–8183. https://doi.org/10.18632/oncotarget.6995
Hsu CW, Shou D, Huang R, Khuc T, Dai S, Zheng W, Klumpp-Thomas C, Xia M (2016c) Identification of HDAC inhibitors using a cell-based HDAC I/II assay. J Biomol Screen 21(6):643–652. https://doi.org/10.1177/1087057116629381
Hsu CW, Zhao J, Xia M (2016d) Transactivation and coactivator recruitment assays for measuring farnesoid X receptor activity. Methods Mol Biol 1473:43–53. https://doi.org/10.1007/978-1-4939-6346-1_5
Hsu CW, Huang R, Attene-Ramos M, Austin CP, Simeonov A, Xia M (2017) Advances in high-throughput screening technology for toxicology. Int J Risk Assess Manag 20(1–3):109–135. https://doi.org/10.1504/ijram.2017.082562
Hsu CW, Zhao J, Huang R, Hsieh JH, Hamm J, Chang X, Houck K, Xia M (2014) Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor. Sci Rep 4:6437. https://doi.org/10.1038/srep06437
Huang R, Sakamuru S, Martin MT, Reif DM, Judson RS, Houck KA, Casey W, Hsieh JH, Shockley KR, Ceger P, Fostel J, Witt KL, Tong W, Rotroff DM, Zhao T, Shinn P, Simeonov A, Dix DJ, Austin CP, Kavlock RJ, Tice RR, Xia M (2014) Profiling of the Tox21 10Â K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway. Sci Rep 4:5664. https://doi.org/10.1038/srep05664
Huang R, Southall N, Cho MH, Xia M, Inglese J, Austin CP (2008) Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening. Chem Res Toxicol 21(3):659–667. https://doi.org/10.1021/tx700365e
Huang R, Xia M, Cho MH, Sakamuru S, Shinn P, Houck KA, Dix DJ, Judson RS, Witt KL, Kavlock RJ, Tice RR, Austin CP (2011) Chemical genomics profiling of environmental chemical modulation of human nuclear receptors. Environ Health Perspect 119(8):1142–1148. https://doi.org/10.1289/ehp.1002952
Huang RL (2016) A quantitative high-throughput screening data analysis pipeline for activity profiling. In: High-throughput screening assays in toxicology, vol 1473, pp 111–122. https://doi.org/10.1007/978-1-4939-6346-1_12
Huang R, Xia M, Nguyen D-T, Zhao T, Sakamuru S, Zhao J, Shahane SA, Rossoshek A, Simeonov A (2016a) Tox21Challenge to build predictive models of nuclear receptor and stress response pathways as mediated by exposure to environmental chemicals and drugs. Front Environ Sci 3 (85). https://doi.org/10.3389/fenvs.2015.00085
Huang R, Xia M, Sakamuru S, Zhao J, Shahane SA, Attene-Ramos M, Zhao T, Austin CP, Simeonov A (2016b) Modelling the Tox21 10Â K chemical profiles for in vivo toxicity prediction and mechanism characterization. Nat Commun 7:10425. https://doi.org/10.1038/ncomms10425
Huang R, Xia M, Sakamuru S, Zhao J, Lynch C, Zhao T, Zhu H, Austin CP, Simeonov A (2018) Expanding biological space coverage enhances the prediction of drug adverse effects in human using in vitro activity profiles. Sci Rep 8(1):3783. https://doi.org/10.1038/s41598-018-22046-w
Inglese J, Auld DS, Jadhav A, Johnson RL, Simeonov A, Yasgar A, Zheng W, Austin CP (2006) Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Natl Acad Sci USA 103(31):11473–11478. https://doi.org/10.1073/pnas.0604348103
Jiang J, Hui CC (2008) Hedgehog signaling in development and cancer. Dev Cell 15(6):801–812. https://doi.org/10.1016/j.devcel.2008.11.010
Johnson JA, Johnson DA, Kraft AD, Calkins MJ, Jakel RJ, Vargas MR, Chen PC (2008) The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann NY Acad Sci 1147:61–69. https://doi.org/10.1196/annals.1427.036
Judson RS, Magpantay FM, Chickarmane V, Haskell C, Tania N, Taylor J, Xia M, Huang R, Rotroff DM, Filer DL, Houck KA, Martin MT, Sipes N, Richard AM, Mansouri K, Setzer RW, Knudsen TB, Crofton KM, Thomas RS (2015) Integrated model of chemical perturbations of a biological pathway using 18 in vitro high-throughput screening assays for the estrogen receptor. Toxicol Sci 148(1):137–154. https://doi.org/10.1093/toxsci/kfv168
Kang JJ, Fang HW (1997) Polycyclic aromatic hydrocarbons inhibit the activity of acetylcholinesterase purified from electric eel. Biochem Biophys Res Commun 238(2):367–369. https://doi.org/10.1006/bbrc.1997.7293
Khuc T, Hsu CW, Sakamuru S, Xia M (2016) Using beta-lactamase and nanoluc luciferase reporter gene assays to identify inhibitors of the HIF-1 signaling pathway. Methods Mol Biol 1473:23–31. https://doi.org/10.1007/978-1-4939-6346-1_3
Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF, Kelly DP (2005) PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3(4):e101. https://doi.org/10.1371/journal.pbio.0030101
Li S, Huang R, Solomon S, Liu Y, Zhao B, Santillo MF, Xia M (2017a) Identification of acetylcholinesterase inhibitors using homogenous cell-based assays in quantitative high-throughput screening platforms. Biotechnol J 12(5). https://doi.org/10.1002/biot.201600715
Li S, Zhao J, Huang R, Steiner T, Bourner M, Mitchell M, Thompson DC, Zhao B, Xia M (2017b) Development and application of human renal proximal tubule epithelial cells for assessment of compound toxicity. Curr Chem Genom Transl Med 11:19–30. https://doi.org/10.2174/2213988501711010019
Li S, Zhao J, Huang R, Santillo MF, Houck KA, Xia M (2019) Use of high-throughput enzyme-based assay with xenobiotic metabolic capability to evaluate the inhibition of acetylcholinesterase activity by organophosphorous pesticides. Toxicol Vitr 56:93–100. https://doi.org/10.1016/j.tiv.2019.01.002
Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Jager S, Vianna CR, Reznick RM, Cui L, Manieri M, Donovan MX, Wu Z, Cooper MP, Fan MC, Rohas LM, Zavacki AM, Cinti S, Shulman GI, Lowell BB, Krainc D, Spiegelman BM (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119(1):121–135. https://doi.org/10.1016/j.cell.2004.09.013
Lionetto MG, Caricato R, Calisi A, Giordano ME, Schettino T (2013) Acetylcholinesterase as a biomarker in environmental and occupational medicine: new insights and future perspectives. Biomed Res Int 2013:321213. https://doi.org/10.1155/2013/321213
Luo J, Sladek R, Carrier J, Bader JA, Richard D, Giguere V (2003) Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Mol Cell Biol 23(22):7947–7956
Lynch C, Mackowiak B, Huang R, Li L, Heyward S, Sakamuru S, Wang H, Xia M (2019a) Identification of modulators that activate the constitutive androstane receptor from the Tox21 10 K compound library. Toxicol Sci 167(1):282–292. https://doi.org/10.1093/toxsci/kfy242
Lynch C, Zhao J, Sakamuru S, Zhang L, Huang R, Witt KL, Merrick BA, Teng CT, Xia M (2019b) Identification of compounds that inhibit estrogen-related receptor alpha signaling using high-throughput screening assays. Molecules 24(5). https://doi.org/10.3390/molecules24050841
Lynch C, Pan Y, Li L, Heyward S, Moeller T, Swaan PW, Wang H (2014) Activation of the constitutive androstane receptor inhibits gluconeogenesis without affecting lipogenesis or fatty acid synthesis in human hepatocytes. Toxicol Appl Pharmacol 279(1):33–42. https://doi.org/10.1016/j.taap.2014.05.009
Lynch C, Pan YM, Li LH, Ferguson SS, Xia MH, Swaan PW, Wang HB (2013) Identification of novel activators of constitutive androstane receptor from FDA-approved drugs by integrated computational and biological approaches. Pharm Res Dordr 30(2):489–501. https://doi.org/10.1007/s11095-012-0895-1
Lynch C, Sakamuru S, Huang R, Stavreva DA, Varticovski L, Hager GL, Judson RS, Houck KA, Kleinstreuer NC, Casey W, Paules RS, Simeonov A, Xia M (2017) Identifying environmental chemicals as agonists of the androgen receptor by using a quantitative high-throughput screening platform. Toxicology 385:48–58. https://doi.org/10.1016/j.tox.2017.05.001
Lynch C, Zhao J, Huang R, Xiao J, Li L, Heyward S, Xia M, Wang H (2015) Quantitative high-throughput identification of drugs as modulators of human constitutive androstane receptor. Sci Rep 5:10405. https://doi.org/10.1038/srep10405
Lynch C, Zhao J, Wang H, Xia M (2016) Quantitative high-throughput luciferase screening in identifying CAR modulators. Methods Mol Biol 1473:33–42. https://doi.org/10.1007/978-1-4939-6346-1_4
Lynch C, Zhao JH, Huang RL, Kanaya N, Bernal L, Hsieh JH, Auerbach SS, Witt KL, Merrick BA, Chen SA, Teng CT, Xia MH (2018) Identification of estrogen-related receptor alpha agonists in the Tox21 compound library. Endocrinology 159(2):744–753. https://doi.org/10.1210/en.2017-00658
Macho A, Decaudin D, Castedo M, Hirsch T, Susin SA, Zamzami N, Kroemer G (1996) Chloromethyl-X-Rosamine is an aldehyde-fixable potential-sensitive fluorochrome for the detection of early apoptosis. Cytometry 25(4):333–340. https://doi.org/10.1002/(SICI)1097-0320(19961201)25:4%3c333:AID-CYTO4%3e3.0.CO;2-E
Massoulie J, Pezzementi L, Bon S, Krejci E, Vallette FM (1993) Molecular and cellular biology of cholinesterases. Prog Neurobiol 41(1):31–91
Matsushima H, Mori T, Ito F, Yamamoto T, Akiyama M, Kokabu T, Yoriki K, Umemura S, Akashi K, Kitawaki J (2016) Anti-tumor effect of estrogen-related receptor alpha knockdown on uterine endometrial cancer. Oncotarget 7(23):34131–34148. https://doi.org/10.18632/oncotarget.9151
Miao Y, He N, Zhu JJ (2010) History and new developments of assays for cholinesterase activity and inhibition. Chem Rev 110(9):5216–5234. https://doi.org/10.1021/cr900214c
Miller SC, Huang R, Sakamuru S, Shukla SJ, Attene-Ramos MS, Shinn P, Van Leer D, Leister W, Austin CP, Xia M (2010) Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action. Biochem Pharmacol 79(9):1272–1280. https://doi.org/10.1016/j.bcp.2009.12.021
Mooser G, Sigman DS (1974) Ligand binding properties of acetylcholinesterase determined with fluorescent probes. Biochemistry 13(11):2299–2307
Nachmansohn D, Wilson IB (1951) The enzymic hydrolysis and synthesis of acetylcholine. Adv Enzymol Relat Subj Biochem 12:259–339
Nishihara K, Huang R, Zhao J, Shahane SA, Witt KL, Smith-Roe SL, Tice RR, Takeda S, Xia M (2016) Identification of genotoxic compounds using isogenic DNA repair deficient DT40 cell lines on a quantitative high throughput screening platform. Mutagenesis 31(1):69–81. https://doi.org/10.1093/mutage/gev055
NRC NRC (1984). In: Toxicity testing: strategies to determine needs and priorities. The National Academies Collection: Reports funded by National Institutes of Health. Washington (DC). https://doi.org/10.17226/317
Park S, Chang CY, Safi R, Liu X, Baldi R, Jasper JS, Anderson GR, Liu T, Rathmell JC, Dewhirst MW, Wood KC, Locasale JW, McDonnell DP (2016) ERRalpha-regulated lactate metabolism contributes to resistance to targeted therapies in breast cancer. Cell Rep 15(2):323–335. https://doi.org/10.1016/j.celrep.2016.03.026
Pihlajamaa P, Sahu B, Janne OA (2015) Determinants of receptor- and tissue-specific actions in androgen signaling. Endocr Rev 36(4):357–384. https://doi.org/10.1210/er.2015-1034
Qatanani M, Moore DD (2005) CAR, the continuously advancing receptor, in drug metabolism and disease. Curr Drug Metab 6(4):329–339
Quinn DM (1987) Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chem Rev 87(5):955–979. https://doi.org/10.1021/cr00081a005
Reddy PM, Philip GH (1994) In vivo inhibition of AChE and ATPase activities in the tissues of freshwater fish, Cyprinus carpio exposed to technical grade cypermethrin. Bull Environ Contam Toxicol 52(4):619–626
Rotroff DM, Martin MT, Dix DJ, Filer DL, Houck KA, Knudsen TB, Sipes NS, Reif DM, Xia M, Huang R, Judson RS (2014) Predictive endocrine testing in the 21st century using in vitro assays of estrogen receptor signaling responses. Environ Sci Technol 48(15):8706–8716. https://doi.org/10.1021/es502676e
Sakamuru S, Attene-Ramos MS, Xia M (2016) Mitochondrial membrane potential assay. Methods Mol Biol 1473:17–22. https://doi.org/10.1007/978-1-4939-6346-1_2
Sakamuru S, Li X, Attene-Ramos MS, Huang R, Lu J, Shou L, Shen M, Tice RR, Austin CP, Xia M (2012) Application of a homogenous membrane potential assay to assess mitochondrial function. Physiol Genomics 44(9):495–503. https://doi.org/10.1152/physiolgenomics.00161.2011
Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A (1997) JC-1, but not DiOC(6)(3) or rhodamine 123, is a reliable fluorescent probe to assess Delta Psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411(1):77–82. https://doi.org/10.1016/S0014-5793(97)00669-8
Santillo MF, Liu Y (2015) A fluorescence assay for measuring acetylcholinesterase activity in rat blood and a human neuroblastoma cell line (SH-SY5Y). J Pharmacol Toxicol Methods 76:15–22. https://doi.org/10.1016/j.vascn.2015.07.002
Shukla SJ, Huang R, Austin CP, Xia M (2010) The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform. Drug Discov Today 15(23–24):997–1007. https://doi.org/10.1016/j.drudis.2010.07.007
Shukla SJ, Huang R, Simmons SO, Tice RR, Witt KL, Vanleer D, Ramabhadran R, Austin CP, Xia M (2012) Profiling environmental chemicals for activity in the antioxidant response element signaling pathway using a high throughput screening approach. Environ Health Perspect 120(8):1150–1156. https://doi.org/10.1289/ehp.1104709
Shukla SJ, Sakamuru S, Huang R, Moeller TA, Shinn P, Vanleer D, Auld DS, Austin CP, Xia M (2011) Identification of clinically used drugs that activate pregnane X receptors. Drug Metab Dispos 39(1):151–159. https://doi.org/10.1124/dmd.110.035105
Sinko G, Calic M, Bosak A, Kovarik Z (2007) Limitation of the Ellman method: cholinesterase activity measurement in the presence of oximes. Anal Biochem 370(2):223–227. https://doi.org/10.1016/j.ab.2007.07.023
Skakkebaek A, Bojesen A, Kristensen MK, Cohen A, Hougaard DM, Hertz JM, Fedder J, Laurberg P, Wallentin M, Ostergaard JR, Pedersen AD, Gravholt CH (2014) Neuropsychology and brain morphology in Klinefelter syndrome-the impact of genetics. Andrology 2(4):632–640. https://doi.org/10.1111/j.2047-2927.2014.00229.x
Soreq H, Seidman S (2001) Acetylcholinesterase–new roles for an old actor. Nat Rev Neurosci 2(4):294–302. https://doi.org/10.1038/35067589
Sultatos LG (1994) Mammalian toxicology of organophosphorus pesticides. J Toxicol Environ Health 43(3):271–289. https://doi.org/10.1080/15287399409531921
Tanaka F, Katsuno M, Banno H, Suzuki K, Adachi H, Sobue G (2012) Current status of treatment of spinal and bulbar muscular atrophy. Neural Plast 2012:369284. https://doi.org/10.1155/2012/369284
Taylor P, Lappi S (1975) Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding. Biochemistry 14 (9):1989–1997
Taylor P, Radic Z (1994) The cholinesterases: from genes to proteins. Annu Rev Pharmacol Toxicol 34:281–320. https://doi.org/10.1146/annurev.pa.34.040194.001433
Teng CT, Beames B, Alex Merrick B, Martin N, Romeo C, Jetten AM (2014) Development of a stable cell line with an intact PGC-1alpha/ERRalpha axis for screening environmental chemicals. Biochem Biophys Res Commun 444(2):177–181. https://doi.org/10.1016/j.bbrc.2014.01.033
Teng CT, Hsieh JH, Zhao J, Huang R, Xia M, Martin N, Gao X, Dixon D, Auerbach SS, Witt KL, Merrick BA (2017) Development of novel cell lines for high-throughput screening to detect estrogen-related receptor alpha modulators. SLAS Discov 22(6):720–731. https://doi.org/10.1177/2472555216689772
Thomas RS, Paules RS, Simeonov A, Fitzpatrick SC, Crofton KM, Casey WM, Mendrick DL (2018) The US federal Tox21 program: a strategic and operational plan for continued leadership. Altex 35(2):163–168. https://doi.org/10.14573/altex.1803011
Wallace KB, Eells JT, Madeira VM, Cortopassi G, Jones DP (1997) Mitochondria-mediated cell injury. Symposium overview. Fundam Appl Toxicol 38(1):23–37
Wang R, Tang XC (2005) Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer’s disease. Neurosignals 14 (1–2):71-82. https://doi.org/10.1159/000085387
Wang Y, Jadhav A, Southal N, Huang R, Nguyen DT (2010) A grid algorithm for high throughput fitting of dose-response curve data. Curr Chem Genomics 4:57–66. https://doi.org/10.2174/1875397301004010057
Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW (1994) Hepatotoxic effects of tacrine administration in patients with Alzheimer’s disease. JAMA 271(13):992–998
Wilson IB, Quan C (1958) Acetylcholinesterase studies on molecular complementariness. Arch Biochem Biophys 73(1):131–143
Witt KL, Hsieh JH, Smith-Roe SL, Xia M, Huang R, Zhao J, Auerbach SS, Hur J, Tice RR (2017) Assessment of the DNA damaging potential of environmental chemicals using a quantitative high-throughput screening approach to measure p53 activation. Environ Mol Mutagen 58(7):494–507. https://doi.org/10.1002/em.22112
Xia M, Huang R, Shi Q, Boyd WA, Zhao J, Sun N, Rice JR, Dunlap PE, Hackstadt AJ, Bridge MF, Smith MV, Dai S, Zheng W, Chu PH, Gerhold D, Witt KL, DeVito M, Freedman JH, Austin CP, Houck KA, Thomas RS, Paules RS, Tice RR, Simeonov A (2018) Comprehensive analyses and prioritization of Tox21 10Â K chemicals affecting mitochondrial function by in-depth mechanistic studies. Environ Health Perspect 126(7):077010. https://doi.org/10.1289/EHP2589
Xie HQ, Xu HM, Fu HL, Hu Q, Tian WJ, Pei XH, Zhao B (2013) AhR-mediated effects of dioxin on neuronal acetylcholinesterase expression in vitro. Environ Health Perspect 121(5):613–618. https://doi.org/10.1289/ehp.1206066
Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR (2004) The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 64(20):7197–7200. https://doi.org/10.1158/0008-5472.CAN-04-1459
Zhao JH, Shukla SJ, Xia MH (2016) Cell-based assay for identifying the modulators of antioxidant response element signaling pathway. In: High-throughput screening assays in toxicology, vol 1473, pp 55–62. https://doi.org/10.1007/978-1-4939-6346-1_6
Zurlo J, Rudacille D, Goldberg AM (1994) Animals and alternatives in testing: history, science, and ethics. Mary Ann Liebert, Inc. Accessed 04 Feb 2019
Acknowledgements
This work was supported in part by the Intramural Research Program of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). The views expressed in this article are those of the authors and do not necessarily reflect the statements, opinions, views, conclusions, or policies of the NCATS, the NIH, or the US Government.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Lynch, C., Sakamuru, S., Li, S., Xia, M. (2020). High-Throughput Screening and Hazard Testing Prioritization. In: Jiang, G., Li, X. (eds) A New Paradigm for Environmental Chemistry and Toxicology. Springer, Singapore. https://doi.org/10.1007/978-981-13-9447-8_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-9447-8_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9446-1
Online ISBN: 978-981-13-9447-8
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)